Windlas Biotech consolidated net profit rises 46.87% in the September 2022 quarter

8 Nov 2022 , 03:57 PM

Net profit of Windlas Biotech rose 46.87% to Rs 12.19 crore in the quarter ended September 2022 as against Rs 8.30 crore during the previous quarter ended September 2021. Sales rose 15.17% to Rs 132.73 crore in the quarter ended September 2022 as against Rs 115.25 crore during the previous quarter ended September 2021.

Particulars	Quarter Ended
?	Sep. 2022	Sep. 2021	% Var.
Sales	132.73	115.25	15
OPM %	12.09	11.41	–
PBDT	18.54	13.94	33
PBT	15.64	10.86	44
NP	12.19	8.30	47

Powered by Capital Market – Live News